The House of Representatives Sept. 26 passed the fiscal year 2019 “minibus” funding bill, increasing the NIH appropriation by $2 billion to $39.1 billion—a 5.4 percent boost over the current level.
A memorial service for Alan Rabson will take place on Oct. 30, from 2 to 4 p.m., at the Ruth L. Kirschstein Auditorium, Natcher Conference Center in Bethesda, MD.
Heidi Nelson, a colorectal surgeon from Mayo Clinic, was named medical director of Cancer Programs in the American College of Surgeons Division of Research and Optimal Patient Care.
The American Cancer Society recognized John Ruckdeschel, director of the University of Mississippi Medical Center Cancer Institute and professor of medicine in the Division of Hematology and Oncology, for his work and his continuing support of the ACS.
The Susan G. Komen organization has awarded a $600,000 research grant to Carlos Arteaga, director of the Harold C. Simmons Comprehensive Cancer Center and associate dean of oncology programs at UT Southwestern Medical Center.
The American Society of Clinical Oncology has presented Rep. Kevin Yoder (R-KS) with the 2018 Congressional Leadership Award.
The National Comprehensive Cancer Network has moved into new headquarters in Plymouth Meeting, PA, near Philadelphia, from Fort Washington, PA. The new location will allow for greater hosting capacity for meetings, guests, and a growing staff.
New York Governor Andrew Cuomo announced Roswell Park Comprehensive Cancer Center has formed the Innovative Immunotherapy Alliance S.A., the first-ever biotech venture between the U.S. and Cuba.
As the fallout from the ethics scandal at Memorial Sloan Kettering Cancer Center continues, cancer center officials are investigating allegations contained in an anonymous letter from a group that identifies themselves as “Concerned Employees of MSKCC.”
Oregon flirts with—and quickly abandons—plan to deny Medicaid payment for next-generation sequencing
The Oregon Health Authority did a considerable amount of work to prepare a plan that would deny Medicaid coverage for next-generation sequencing tests in the state.
